Join us for the 2024 Huntington Disease Education Day on Saturday, October 12, from 10:00 AM to 1:30 PM, hosted by the University of Florida Health HDSA Center of Excellence. This virtual event will offer valuable insights for patients and caregivers, featuring expert presentations by Dr. Nikolaus McFarland and specialists…
The UF Fixel Institute is a site participating in the GENERATION HD2 trial, sponsored by Roche-Genentech. This trial is studying an investigational drug (Tominersen) designed to target the Huntingin protein. See the following for more information: Contact info: Randy.Foli@neurology.ufl.edu…
By. Mallory Bachmann As the Norman Fixel Institute for Neurological Diseases at UF Health celebrates one year of magnetoencephalography (MEG) operations, the lab proudly announces more than 100 cases using the MEG scanner. The MEG scanner plays a critical role in research and patient care by providing detailed data on…
Parkinson's Symposium REcorded Webinars Watch Here Miss the 2024 Annual Parkinson's Sympsoium? Do not worry, as all talks have been posted to the Fixel YouTube page where you can learn…
New research by a University of Florida-led international team has revealed evidence linking a new genetic mutation to greater risk of developing Parkinson’s disease.
Under the leadership of Drs. Matthew Burns and Sub Subramony, the Fixel Institute receives recognition as an Ataxia Center of Excellence by the National Ataxia Foundation.
Check in with the National Ataxia Foundation library of resources ranging from medication, to exercise, to caregiver resources and more.
SKYCLARYS was tested and approved by the FDA to treat Friedrich’s ataxia.
Under the direction of Dr. Nikolaus McFarland, the Fixel Institute receives renewal as a Huntington’s Disease Society of America (HDSA) Center of Excellence.
Researchers discover using icepacks on the arms and hands may reduce or stop tremors caused by tacrolimus, a medication used for immune system suppression after organ transplant surgery.
